Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MKO Melt for Sedation in Cataract Surgery
NCT03653520Completed
- Sponsor
- Avanti Anesthesia
- Start
- Jun 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of MKO Melt in cataract (3 arms), sponsored by Avanti Anesthesia. Primary endpoint: Number of patients who needed additional IV medication for cataract surgery at 1 day. Started Jun 2017; status: completed.
02
Drugs
MKO Melt
03
Conditions
cataract
Beyond the preview
Go deeper on NCT03653520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03653520.